PubMed

Increased PAI-1 plasma levels and risk of death from dengue: no association with the 4G/5G promoter polymorphism.

Mairuhu AT, Setiati TE, Koraka P, Hack CE, Leyte A, Faradz SM, ten Cate H, Brandjes DP, Osterhaus AD, Reitsma PH, van Gorp EC.

Thromb J. 2005 Nov 7;3:17.PMID: 16274483 [PubMed]Related articlesFree article

4G/5G promoter polymorphism in the plasminogen-activator-inhibitor-1 gene and outcome of meningococcal disease. Meningococcal Research Group.

Hermans PW, Hibberd ML, Booy R, Daramola O, Hazelzet JA, de Groot R, Levin M.

Lancet. 1999 Aug 14;354(9178):556-60.PMID: 10470700 [PubMed - indexed for MEDLINE]Related articles

Plasminogen activator inhibitor-1 4G/5G gene polymorphism in patients with myocardial or cerebrovascular infarction in Tianjin, China.

Zhan M, Zhou Y, Han Z.

Chin Med J (Engl). 2003 Nov;116(11):1707-10.PMID: 14642142 [PubMed - indexed for MEDLINE]Related articlesFree article

4G/5G polymorphism of plasminogen activator inhibitor-1 gene is associated with mortality in intensive care unit patients with severe pneumonia.

Sapru A, Hansen H, Ajayi T, Brown R, Garcia O, Zhuo H, Wiemels J, Matthay MA, Wiener-Kronish J.

Anesthesiology. 2009 May;110(5):1086-91.PMID: 19387177 [PubMed - indexed for MEDLINE]Related articlesFree article

Allelic frequency of the PAI-1 4G/5G promoter polymorphism in patients with type 2 diabetes mellitus and lack of association with PAI-1 plasma levels.

Zietz B, Buechler C, Drobnik W, Herfarth H, Schölmerich J, Schäffler A.

Endocr Res. 2004 Aug;30(3):443-53.PMID: 15554360 [PubMed - indexed for MEDLINE]Related articles

[The study of PAI-1 promotor region gene polymorphism in cerebrovascular disease]

Zhang C, Li J, Li L, Luo B.

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2001 Oct;18(5):383-7. Chinese. PMID: 11592048 [PubMed - indexed for MEDLINE]Related articles

Plasminogen activator inhibitor-1 (PAI-1) gene polymorphism (-675 4G/5G) associated with obesity and vascular risk in children.

Berberoğlu M, Evliyaoğlu O, Adiyaman P, Ocal G, Ulukol B, Simşek F, Siklar Z, Törel A, Ozel D, Akar N.

J Pediatr Endocrinol Metab. 2006 May;19(5):741-8.PMID: 16789641 [PubMed - indexed for MEDLINE]Related articles

Plasminogen activator inhibitor-1 4G/5G polymorphism in breast cancer patients and its association with tissue PAI-1 levels and tumor severity.

Castelló R, España F, Vázquez C, Fuster C, Almenar SM, Aznar J, Estellés A.

Thromb Res. 2006;117(5):487-92.PMID: 15907980 [PubMed - indexed for MEDLINE]Related articles

Plasminogen activator inhibitor type-1 (PAI-1) polymorphism 4G/5G is associated with prostate cancer among men with a positive family history.

Jorgenson E, Deitcher SR, Cicek M, Liu X, Plummer S, Casey G, Witte JS.

Prostate. 2007 Feb 1;67(2):172-7.PMID: 17044080 [PubMed - indexed for MEDLINE]Related articles

The plasminogen activator inhibitor-1 (PAI-1) gene -844 A/G and -675 4G/5G promoter polymorphism significantly influences plasma PAI-1 levels in women with polycystic ovary syndrome.

Lin S, Huiya Z, Bo L, Wei W, Yongmei G.

Endocrine. 2009 Oct 24. [Epub ahead of print]PMID: 19856137 [PubMed - as supplied by publisher]Related articles

The -675 4G/5G polymorphism at the Plasminogen Activator Inhibitor 1 (PAI-1) gene modulates plasma Plasminogen Activator Inhibitor 1 concentrations in response to dietary fat consumption.

Pérez-Martínez P, Adarraga-Cansino MD, Fernández de la Puebla RA, Blanco-Molina A, Delgado-Lista J, Marín C, Ordovás JM, López-Miranda J, Pérez-Jiménez F.

Br J Nutr. 2008 Apr;99(4):699-702. Epub 2007 Oct 1.PMID: 17903340 [PubMed - indexed for MEDLINE]Related articles

Contribution of the type 1 plasminogen activator inhibitor 4G/5G gene polymorphism to impaired fibrinolysis in vital exhaustion.

von Känel R, Maly FE, Frey K, Fischer JE.

Ital Heart J. 2003 Nov;4(11):791-6.PMID: 14699709 [PubMed - indexed for MEDLINE]Related articles

PAI-1 4G/5G insertion/deletion promoter polymorphism and microvascular complications in type 2 diabetes mellitus.

Funk M, Endler G, Exner M, Marculescu R, Endler L, Abrahamian H, Mauler H, Grimm A, Raith M, Mannhalter C, Prager R, Irsigler K, Wagner OF.

Wien Klin Wochenschr. 2005 Oct;117(19-20):707-10.PMID: 16416371 [PubMed - indexed for MEDLINE]Related articles

4G/5G PAI-1 promoter polymorphism and acute-phase levels of PAI-1 following coronary bypass surgery: a prospective study.

Burzotta F, Iacoviello L, Di Castelnuovo A, Zamparelli R, D'Orazio A, Amore C, Schiavello R, Donati MB, Maseri A, Possati G, Andreotti F.

J Thromb Thrombolysis. 2003 Dec;16(3):149-54.PMID: 15087600 [PubMed - indexed for MEDLINE]Related articles

The plasminogen activator inhibitor (PAI-1) 4G/5G promoter polymorphism and PAI-1 levels in ischemic stroke. A case-control study.

van Goor ML, Gómez García E, Leebeek F, Brouwers GJ, Koudstaal P, Dippel D.

Thromb Haemost. 2005 Jan;93(1):92-6.PMID: 15630497 [PubMed - indexed for MEDLINE]Related articles

The -675 4G/5G plasminogen activator inhibitor-1 promoter polymorphism in house dust mite-sensitive allergic asthma patients.

Pampuch A, Kowal K, Bodzenta-Lukaszyk A, Di Castelnuovo A, Chyczewski L, Donati MB, Iacoviello L.

Allergy. 2006 Feb;61(2):234-8.PMID: 16409202 [PubMed - indexed for MEDLINE]Related articles

The 4G/5G polymorphism in the plasminogen activator inhibitor-1 gene is not associated with HELLP syndrome.

Muetze S, Eggermann T, Leeners B, Birke C, Kuse S, Ortlepp JR, Rudnik-Schoeneborn S, Zerres K, Rath W.

J Thromb Thrombolysis. 2009 Feb;27(2):141-5. Epub 2007 Dec 6.PMID: 18058192 [PubMed - indexed for MEDLINE]Related articles

4G/4G genotype of PAI-1 gene is associated with reduced risk of stroke in elderly.

Hoekstra T, Geleijnse JM, Kluft C, Giltay EJ, Kok FJ, Schouten EG.

Stroke. 2003 Dec;34(12):2822-8. Epub 2003 Nov 6.PMID: 14605330 [PubMed - indexed for MEDLINE]Related articlesFree article

Diabetic retinopathy, PAI-1 4G/5G and -844G/A polymorphisms, and changes in circulating PAI-1 levels in Tunisian type 2 diabetes patients.

Ezzidi I, Mtiraoui N, Chaieb M, Kacem M, Mahjoub T, Almawi WY.

Diabetes Metab. 2009 Jun;35(3):214-9. Epub 2009 May 5.PMID: 19419896 [PubMed - indexed for MEDLINE]Related articles

Plasminogen activator inhibitor 1 expression in platelets is not influenced by the 4G/5G promoter polymorphism.

Brogren H, Wallmark K, Jern S, Karlsson L.

Thromb Res. 2008;121(6):793-7. Epub 2007 Sep 19.PMID: 17884148 [PubMed - indexed for MEDLINE]Related articles